NY-INVESTABLE-UNIVERSE
22.9.2021 10:17:14 CEST | Business Wire | Press release
The real assets news site Investable Universe announces the launch of Polar Futures , a media series that examines the eight-nation Arctic region’s growing geopolitical importance and its potential for attracting hundreds of billions of dollars in direct investment to develop the region and its bounty of natural resources.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210922005180/en/
Institutional investors, pension funds and other investors are eyeing the potential of developing infrastructure, shipping, logistics, telecommunications, mining, aquaculture and marine resources and of incubating technologies that aid the transition to renewable energy.
Additionally, new trans-Arctic shipping lanes made more accessible by climate change will focus competing political and military interests on the polar zone.
Nuanced insights from pivotal figures
Against this fluid strategic backdrop, the weekly newsletter and podcast series, curated by editor-in-chief Rebecca Engmann Darst, will feature interviews with pivotal figures in the Arctic discourse, including:
- Greenlandic Minister of Foreign Affairs, Trade, Business and Climate Pele Broberg, on Greenland’s political atmosphere and the new government’s priorities for independence, social welfare and environmental protection
- Ambassador Einar Gunnarsson, who was Chair of the Senior Arctic Officials during Iceland’s chairmanship of the Arctic Council from 2019 to 2021, on Iceland’s role on the council and its recent transition of leadership to Russia
- Leslie Canavera, CEO of PolArctic LLC , an Alaska Native-owned small business, and Chair of the Arctic Economic Council Blue Economy Working Group, on the challenges and opportunities for AI models to support Arctic business and environmental sustainability
- Mac McHale, CRO of Alaskan telecommunications developer Quintillion and a 30-year veteran of broadband development, on the obstacles and potential of the U.S. Arctic telecom infrastructure buildout and how the region offers a test case not only for rugged Earth environments but also for space
- Anne Kirstine Hermann, a Danish journalist and the author of the new book Imperiets Børn (Children of the Empire) , on the legacy of Denmark’s compulsory integration of Greenland in the 1950s, the role of the United Nations and how these complex historical and cultural relationships might affect current and future Arctic development.
The series also will include insights about the roles of Canada, Finland, Norway, Russia and Sweden in the rapidly evolving Arctic zone.
Subscribers will gain exclusive access to nuanced transnational views of the polar investment and geopolitical landscape through a weekly newsletter and podcast interviews with guests from across the diplomatic, media and entrepreneurial spectrum.
Will globalization and climate change spur great-power rivalry in the Arctic?
Noting that research from the Council on Foreign Relations examined the Arctic as a potential site for “the return of great-power rivalry”[1] amid the challenges of globalization and climate change, Darst believes that the Arctic North will be the nexus of a number of conflicts and opportunities in the twenty-first century.
“The polar region’s strategic value is hard to overstate. It holds vast natural and mineral resources and is developing new and high-tech industries in parallel to those riches. Yet in the region, there’s also an intricate tapestry of historical and cultural factors that are rarely discussed on a global level. We will delve unflinchingly into all of them in the newsletter and podcast,” says Darst.
Subscribe to the Polar Futures newsletter and podcast bundle at www.investableuniverse.com/polarfutures .
About Investable Universe
Trofast Media’s Investable Universe provides leading edge insights into investment in real assets, the global “market of things” that spans traditional investments and emerging technologies on earth and in space.
Learn more at InvestableUniverse.com .
[1] https://www.cfr.org/in-brief/whats-stake-rising-competition-arctic
View source version on businesswire.com: https://www.businesswire.com/news/home/20210922005180/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
